Yasemi̇n Kemal

530 citations
27 papers · 334 indexed · h-index 9

Yasemi̇n Kemal

25 papers receiving 328 citations

Peers

Yasemi̇n Kemal
Comparison fields: 5 of 53
  • Oncology 264
  • Internal Medicine 19
  • Cancer Research 75
  • Reproductive Medicine 36
  • Obstetrics and Gynecology 24
Replace Arzu Oğuz with:
Arzu Oğuz Türkiye
Takashi SATOMI Japan
Kiyoshi Kubochi Japan
Xun Yang China
Yiping Du China
Cui-jian Zhang China
Katrin Hefler‐Frischmuth Austria
Fatih Teker Türkiye
Sabine Krenn-Pilko Austria
Suna Çokmert Türkiye
Yasemi̇n Kemal relative to Arzu Oğuz Türkiye Arzu Oğuz's profile →
Citations per field
00.5×2.7×
Arzu Oğuz · 1×
Citations per year

Countries citing papers authored by Yasemi̇n Kemal

Since Specialization
Citations

This map shows the geographic impact of Yasemi̇n Kemal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasemi̇n Kemal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasemi̇n Kemal more than expected).

Fields of papers citing papers by Yasemi̇n Kemal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasemi̇n Kemal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasemi̇n Kemal. The network helps show where Yasemi̇n Kemal may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yasemi̇n Kemal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yasemi̇n Kemal Line = papers co-authored together Yasemi̇n Kemal links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20214
3 20201
4 20191
5 201814
6 20181
7 201826
8 20173
9 201713
10 20169
11
Virchow's node metastasis: an unusual presentation of ovarian cancer.
20163
12 20158
13 201459
14 2014100
15 20148
16
Single dose regorafenib-induced hypertensive crisis.
20143
17 201440
18 20121
19 20121
20 20084

About Yasemi̇n Kemal

Yasemi̇n Kemal is a scholar working on Oncology, Cancer Research and Reproductive Medicine, having authored 27 papers that have together received 334 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (7 papers), Cancer Diagnosis and Treatment (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Cancer, Lipids, and Metabolism (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Brain Metastases and Treatment (2 papers), Metastasis and carcinoma case studies (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Oncology (264 citations), Internal Medicine (19 citations) and Cancer Research (75 citations). Yasemi̇n Kemal has collaborated with scholars based in Türkiye, Spain and United States. Frequent co-authors include Güzin Demirağ, İdris Yücel, Fatih Teker, İstemi Yücel, Meltem Özdemir, Mehmet Kefeli, Di̇lek Erdem, Leman Tomak, Abdülkerim Bedir and Romualdo Barroso‐Sousa. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026